Antiviral drug resistance

被引：84

作者：

Richman, Douglas D.

机构：

[1] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA

[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA

来源：

ANTIVIRAL RESEARCH | 2006年 / 71卷 / 2-3期

关键词：

antiviral drugs; drug resistance; HIV; influenza; herpesviruses;

D O I：

10.1016/j.antiviral.2006.03.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Almost 30 years ago it was proposed that the selection for antiviral drug resistance should be used as an indicator of antiviral drug activity. In addition to discriminating between cellular toxicity and specific activity directed against a viral target, drug resistant mutants have been used to confirm the mechanism of action of antiviral drugs, to discover the functions of several viral proteins and to provide insights into viral evolution and fitness. Drug resistance has also become a standard component of both the preclinical and clinical drug development process. For HIV and increasingly for other viruses drug resistance testing has become standard-of-care in clinical practice. A few selected examples are provided to illustrate each of these points. Published by Elsevier B.V.

引用

收藏

页码：117 / 121

页数：5

相关论文

共 56 条

[1] Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT):: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase [J].

Arion, D ;

Kaushik, N ;

McCormick, S ;

Borkow, G ;

Parniak, MA .

BIOCHEMISTRY, 1998, 37 (45) :15908-15917

[2] Current concepts - Avian influenza A (H5N1) infection in humans [J].

Beigel, H ;

Farrar, H ;

Han, AM ;

Hayden, FG ;

Hyer, R ;

de Jong, MD ;

Lochindarat, S ;

Tien, NTK ;

Hien, NT ;

Hien, TT ;

Nicoll, A ;

Touch, S ;

Yuen, KY .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385

[3] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J].

BIRON, KK ;

FYFE, JA ;

STANAT, SC ;

LESLIE, LK ;

SORRELL, JB ;

LAMBE, CU ;

COEN, DM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8769-8773

[4] Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern [J].

Bright, RA ;

Medina, MJ ;

Xu, XY ;

Perez-Oronoz, G ;

Wallis, TR ;

Davis, XHM ;

Povinelli, L ;

Cox, NJ ;

Klimov, AI .

LANCET, 2005, 366 (9492) :1175-1181

[5]

Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989

[6] THE CLINICAL SIGNIFICANCE OF THE EMERGENCE OF DRUG-RESISTANT ORGANISMS DURING THE THERAPY OF CHRONIC PULMONARY TUBERCULOSIS WITH HYDRAZIDES OF ISONICOTINIC ACID [J].

COATES, EO ;

MEADE, GM ;

STEENKEN, W ;

WOLINSKY, E ;

BRINKMAN, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1953, 248 (26) :1081-1087

[7]

Coen DM, 1996, ADV EXP MED BIOL, V394, P49

[8] COMBINED DRUG TREATMENT OF TUBERCULOSIS .1. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID INVITRO [J].

COHN, ML ;

MIDDLEBROOK, G ;

RUSSELL, WF .

JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (08) :1349-1355

[9] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].

Deeks, SG ;

Wrin, T ;

Liegler, T ;

Hoh, R ;

Hayden, M ;

Barbour, JD ;

Hellmann, NS ;

Petropoulos, CJ ;

McCune, JM ;

Hellerstein, MK ;

Grant, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480

[10] Mutation rates among RNA viruses [J].

Drake, JW ;

Holland, JJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13910-13913

← 1 2 3 4 5 6 →